Page 24 - 《中国药房》2022年1期
P. 24

Cell Res,2011,317(10):1437-1453.                    cals,metals and antioxidants in oxidative stress-induced
        [11]  ESUMI K,NISHIDA M,SHAW D,et al. NADH measure-      cancer[J]. Chem Biol Interact,2006,160(1):1-40.
             ments in adult rat myocytes during simulated ischemia[J].  [20]  SIES H. Oxidative stress:oxidants and antioxidants[J].
             Am J Physiol,1991,260(6 Pt 2):H1743-H1752.          Exp Physiol,1997,82(2):291-295.
        [12]  RESHMA P L,LEKSHMI V S,SANKAR V,et al. Tribu-  [21]  阿瓦古丽·达吾提,方莲花,杜冠华.丹酚酸对缺血性心脏
             lus terrestris(linn.)attenuates cellular alterations induced  病的作用及作用机制研究进展[J].药学学报,2021,56
             by ischemia in H9c2 cells via antioxidant potential[J].  (2):368-373.
             Phytother Res,2015,29(6):933-943.              [22]  JI C C,SONG F,HUANG G Y,et al. The protective
        [13]  RESHMA P L,BINU P,ANUPAMA N,et al. Pretreat-       effects of acupoint gel embedding on rats with myocardial
             ment of Tribulus terrestris L. causes anti-ischemic cardio-  ischemia-reperfusion injury[J]. Life Sci,2018,211:51-62.
             protection through MAPK mediated anti-apoptotic path-  [23]  MASUDA T,YAMADA K,MAEKAWA T,et al. Antioxi-
             way in rat[J]. Biomed Pharmacother,2019,111:1342-   dant mechanism studies on ferulic acid:isolation and
             1352.                                               structure identification of the main antioxidation product
        [14]  KIKUZAKI H,HISAMOTO M,HIROSE K,et al. Antioxi-     from methyl ferulate[J]. Food Sci Technol Res,2006,12
             dant properties of ferulic acid and its related com-  (3):173-177.
             pounds[J]. J Agric Food Chem,2002,50(7):2161-2168.  [24]  MCCULLY J D,ROUSOU A J,PARKER R A,et al. Age-
        [15]  OU S Y,KWOK K C. Ferulic acid:pharmaceutical func-  and gender-related differences in mitochondrial oxygen
             tions,preparation and applications in foods[J]. J Sci Food  consumption and calcium with cardioplegia and diazoxide
             Agric,2004,84(11):1261-1269.                        [J]. Ann Thorac Surg,2007,83(3):1102-1109.
        [16]  WANG F,PENG Q Q,LIU J F,et al. A novel ferulic acid  [25]  JIA P Y,LIU C T,WU N,et al. Agomelatine protects
             derivative attenuates myocardial cell hypoxia reoxygena-  against myocardial ischemia reperfusion injury by inhibi-
             tion injury through a succinate dehydrogenase dependent  ting mitochondrial permeability transition pore opening[J].
             antioxidant mechanism[J]. Eur J Pharmacol,2019,856:  Am J Transl Res,2018,10(5):1310-1323.
             172417.                                        [26]  ZHANG C,YUAN X R,HU Z L,et al. Valproic acid pro-
        [17]  王献钊,刘明娣.阿魏酸及阿魏酸乙酯的合成[J].湖南城                        tects primary dopamine neurons from MPP -induced neu-
                                                                                                 +
             市学院学报(自然科学版),2007,16(4):63-65.                      rotoxicity:involvement of GSK3β phosphorylation by Akt
        [18]  CHANG S S,LEE V S,TSENG Y L,et al. Gallic acid at-  and ERK through the mitochondrial intrinsic apoptotic
             tenuates platelet activation and platelet-leukocyte aggrega-  pathway[J]. Biomed Res Int,2017,2017:8124501.
             tion:involving pathways of Akt and GSK3β[J]. Evid Based      (收稿日期:2021-08-17  修回日期:2021-12-02)
             Complement Alternat Med,2012,2012:683872.                                           (编辑:舒安琴)
        [19]  VALKO M,RHODES C J,MONCOL J,et al. Free radi-



        



        (上接第12页)                                                 1978,2(6):429-444.
        [12]  王庆金,王强,周雪.区域高技术产业研发活动效率评价                     [18]  KAO C A,HWANG S N. Efficiency decomposition in
             及影响因素研究[J].科技进步与对策,2018,35(23):                     two-stage data envelopment analysis:an application to
             59-65.                                              non-life insurance companies in Taiwan[J]. Eur J Oper
        [13]  韩兵,苏屹,李彤,等.基于两阶段 DEA 的高技术企业技                       Res,2008,185(1):418-429.
             术创新绩效研究[J].科研管理,2018,39(3):11-19.              [19]  王辉,陈敏.基于两阶段 DEA 模型的高校科技创新对区
        [14]  刘和东,陈文潇.高新技术企业创新系统“黑箱”解构及效                         域创新绩效影响[J].经济地理,2020,40(8):27-35,42.
             率评价[J].科技进步与对策,2019,36(3):117-122.             [20]  王新红,薛泽蓉,张行.基于两阶段DEA模型的混合所有
        [15]  郑义,董朝晖,董丽娟,等.我国上市医药企业技术创新效                         制企业创新效率测度研究:基于制造业上市企业的经验
             率及影响因素研究[J].现代商贸工业,2019,40(18):                     数据[J].科技管理研究,2018,38(14):61-67.
             12-16.                                         [21]  陈莹文,王美强,陈银银,等.基于改进两阶段 DEA 的中
        [16]  杨茜.基于共享投入关联DEA的上市医药制造企业创新                          国高技术产业研发创新效率研究[J].软科学,2018,32
             效率评价研究[D].绵阳:西南科技大学,2018.                          (9):14-18.
        [17]  CHARNES A,COOPER W W,RHODES E. Measuring                    (收稿日期:2021-06-08  修回日期:2021-11-03)
             the efficiency of decision making units[J]. Eur J Oper Res,                         (编辑:刘明伟)


        ·18 ·   China Pharmacy 2022 Vol. 33 No. 1                                    中国药房    2022年第33卷第1期
   19   20   21   22   23   24   25   26   27   28   29